Chatbots in Cancer Applications, Advantages and Disadvantages: All that Glitters Is Not Gold
Abstract
:1. Introduction
2. The Novel Chatbots in Medicine and Cancer
3. The Benefits of Chatbots in Medicine and Cancer
4. The Disadvantages of Chatbots in Medicine and Cancer
5. The Current Issues and Challenges of Chatbots
6. The Expert Opinion on Chatbots and Oncology: All That Glitters Is Not Gold
7. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Meskó, B. COVID-19’s Impact on Digital Health Adoption: The Growing Gap between a Technological and a Cultural Transformation. JMIR Hum. Factors 2022, 9, e38926. [Google Scholar] [CrossRef]
- Yang, K.; Hu, Y.; Qi, H. Digital Health Literacy: Bibliometric Analysis. J. Med. Internet Res. 2022, 24, e35816. [Google Scholar] [CrossRef] [PubMed]
- Mouliou, D.S.; Pantazopoulos, I.; Gourgoulianis, K.I. COVID-19 Smart Diagnosis in the Emergency Department: All-in in Practice. Expert. Rev. Respir. Med. 2022, 16, 263–272. [Google Scholar] [CrossRef] [PubMed]
- Xue, J.; Zhang, B.; Zhao, Y.; Zhang, Q.; Zheng, C.; Jiang, J.; Li, H.; Liu, N.; Li, Z.; Fu, W.; et al. Evaluation of the Current State of Chatbots for Digital Health: Scoping Review. J. Med. Internet Res. 2023, 25, e47217. [Google Scholar] [CrossRef] [PubMed]
- Global Cancer Burden Growing, amidst Mounting Need for Services. Available online: https://www.who.int/news/item/01-02-2024-global-cancer-burden-growing--amidst-mounting-need-for-services (accessed on 9 June 2024).
- McTear, M.; Callejas, Z.; Griol, D. The Conversational Interface; Springer International Publishing: Cham, Switzerland, 2016; ISBN 9783319329659. [Google Scholar]
- Nicolescu, L.; Tudorache, M.T. Human-Computer Interaction in Customer Service: The Experience with AI Chatbots—A Systematic Literature Review. Electronics 2022, 11, 1579. [Google Scholar] [CrossRef]
- Hannigan, T.R.; McCarthy, I.P.; Spicer, A. Beware of Botshit: How to Manage the Epistemic Risks of Generative Chatbots. Bus. Horiz. 2024; in press. [Google Scholar] [CrossRef]
- Turing, A.M. I.—Computing machinery and intelligence. Mind 1950, LIX, 433–460. [Google Scholar] [CrossRef]
- Weizenbaum, J. ELIZA—A Computer Program for the Study of Natural Language Communication between Man and Machine. Commun. ACM 1966, 9, 36–45. [Google Scholar] [CrossRef]
- Xu, L.; Sanders, L.; Li, K.; Chow, J.C.L. Chatbot for Health Care and Oncology Applications Using Artificial Intelligence and Machine Learning: Systematic Review. JMIR Cancer 2021, 7, e27850. [Google Scholar] [CrossRef]
- AbuShawar, B.; Atwell, E. ALICE Chatbot: Trials and Outputs. Comput. y Sist. 2015, 19, 625–632. [Google Scholar] [CrossRef]
- Amalia, A.; Suprayogi, M. Engaging Millennials on Using Chatbot Messenger for Eco-Tourism; Atlantis Press: Paris, France, 2019; pp. 484–487. [Google Scholar]
- Chandel, S.; Yuying, Y.; Yujie, G.; Razaque, A.; Yang, G. Chatbot: Efficient and Utility-Based Platform. In Proceedings of the Intelligent Computing; Arai, K., Kapoor, S., Bhatia, R., Eds.; Springer International Publishing: Cham, Switzerland, 2019; pp. 109–122. [Google Scholar]
- Kim, Y.; Lee, H. The Rise of Chatbots in Political Campaigns: The Effects of Conversational Agents on Voting Intention. Int. J. Hum. Comput. Interact. 2023, 39, 3984–3995. [Google Scholar] [CrossRef]
- Lin, P.-C.; Yankson, B.; Lu, Z.; Hung, P.C.K. Children Privacy Identification System in LINE Chatbot for Smart Toys. In Proceedings of the 2019 IEEE 12th International Conference on Cloud Computing (CLOUD), Milan, Italy, 8–13 July 2019; pp. 86–90. [Google Scholar]
- Lai, S.-T.; Leu, F.-Y.; Lin, J.-W. A Banking Chatbot Security Control Procedure for Protecting User Data Security and Privacy. In Proceedings of the Advances on Broadband and Wireless Computing, Communication and Applications; Barolli, L., Leu, F.-Y., Enokido, T., Chen, H.-C., Eds.; Springer International Publishing: Cham, Switzerland, 2019; pp. 561–571. [Google Scholar]
- Liu, L.; Subbareddy, R.; Raghavendra, C.G. AI Intelligence Chatbot to Improve Students Learning in the Higher Education Platform. J. Interconnect. Netw. 2022, 22, 2143032. [Google Scholar] [CrossRef]
- Sun, G.; Zhou, Y.-H. AI in Healthcare: Navigating Opportunities and Challenges in Digital Communication. Front. Digit. Health 2023, 5, 1291132. [Google Scholar] [CrossRef] [PubMed]
- Goel, R.; Goswami, R.P.; Totlani, S.; Arora, P.; Bansal, R.; Vij, D. Machine learning based healthcare chatbot. In Proceedings of the 2022 2nd International Conference on Advance Computing, Innovative Technologies in Engineering (ICACITE), Greater Noida, India, 28–29 April 2022; pp. 188–192. [Google Scholar]
- Kocakoç, I.D. The role of artificial intelligence in health care. In The Impact of Artificial Intelligence on Governance, Economics, Finance; Springer: New York, NY, USA, 2022; Volume 2, pp. 189–206. [Google Scholar]
- FitCircle: Where Bots Make Daily Eating Habits Healthier. Available online: https://www.firstpost.com/tech/startup/fitcircle-where-bots-make-daily-eating-habits-healthier-3725943.html (accessed on 10 June 2024).
- Sawers, P. Gymbot: A Bot That Tracks Your Workouts through Facebook Messenger; VentureBeat: San Francisco, CA, USA, 2016. [Google Scholar]
- Rahmanti, A.R.; Yang, H.-C.; Bintoro, B.S.; Nursetyo, A.A.; Muhtar, M.S.; Syed-Abdul, S.; Li, Y.-C.J. SlimMe, a Chatbot with Artificial Empathy for Personal Weight Management: System Design and Finding. Front. Nutr. 2022, 9, 870775. [Google Scholar] [CrossRef]
- Mendel AI—Know More, Know Now. Available online: https://www.mendel.ai/ (accessed on 10 June 2024).
- Medical-Chat Bot: The History of Our Attempt to Do It—Andrey Lukyanenko. Available online: https://andlukyane.com/blog/medical-chat-bot (accessed on 10 June 2024).
- Bouabida, K.; Lebouché, B.; Pomey, M.-P. Telehealth and COVID-19 Pandemic: An Overview of the Telehealth Use, Advantages, Challenges, and Opportunities during COVID-19 Pandemic. Healthcare 2022, 10, 2293. [Google Scholar] [CrossRef] [PubMed]
- Ahaskar, A. How WhatsApp Chatbots Are Helping in the Fight against COVID-19. Available online: https://www.livemint.com/technology/tech-news/how-whatsapp-chatbots-are-helping-in-the-fight-against-covid-19-11585310168911.html (accessed on 10 June 2024).
- India’s Coronavirus Chatbot on WhatsApp Crosses 1.7 Crore Users in 10 Days. Available online: https://www.gadgets360.com/apps/news/coronavirus-mygov-corona-helpdesk-chatbot-whatsapp-indian-government-total-users-haptik-2204458 (accessed on 10 June 2024).
- Matic, R.; Kabiljo, M.; Zivkovic, M.; Cabarkapa, M. Extensible Chatbot Architecture Using Metamodels of Natural Language Understanding. Electronics 2021, 10, 2300. [Google Scholar] [CrossRef]
- Developing AI Chatbots: Challenges and Considerations. Available online: https://www.linkedin.com/pulse/developing-ai-chatbots-challenges-considerations-artemakis-artemiou-yelif (accessed on 12 June 2024).
- Hien, H.T.; Cuong, P.-N.; Nam, L.N.H.; Nhung, H.L.T.K.; Thang, L.D. Intelligent Assistants in Higher-Education Environments: The FIT-EBot, a Chatbot for Administrative and Learning Support. In Proceedings of the 9th International Symposium on Information and Communication Technology; Association for Computing Machinery: New York, NY, USA, 2018; pp. 69–76. [Google Scholar]
- Kucherbaev, P.; Bozzon, A.; Houben, G.-J. Human-Aided Bots. IEEE Internet Comput. 2018, 22, 36–43. [Google Scholar] [CrossRef]
- Ta, V.; Griffith, C.; Boatfield, C.; Wang, X.; Civitello, M.; Bader, H.; DeCero, E.; Loggarakis, A. User Experiences of Social Support From Companion Chatbots in Everyday Contexts: Thematic Analysis. J. Med. Internet Res. 2020, 22, e16235. [Google Scholar] [CrossRef]
- Medeiros, L.; Gerritsen, C.; Bosse, T. Towards Humanlike Chatbots Helping Users Cope with Stressful Situations. In Proceedings of the Computational Collective Intelligence; Nguyen, N.T., Chbeir, R., Exposito, E., Aniorté, P., Trawiński, B., Eds.; Springer International Publishing: Cham, Switzerland, 2019; pp. 232–243. [Google Scholar]
- Medeiros, L.; Bosse, T.; Gerritsen, C. Can a Chatbot Comfort Humans? Studying the Impact of a Supportive Chatbot on Users’ Self-Perceived Stress. IEEE Trans. Hum. Mach. Syst. 2022, 52, 343–353. [Google Scholar] [CrossRef]
- Jin, E.; Eastin, M.S. Birds of a Feather Flock Together: Matched Personality Effects of Product Recommendation Chatbots and Users. J. Res. Interact. Mark. 2022, 17, 416–433. [Google Scholar] [CrossRef]
- Badlani, S.; Aditya, T.; Dave, M.; Chaudhari, S. Multilingual Healthcare Chatbot Using Machine Learning. In Proceedings of the 2021 2nd International Conference for Emerging Technology (INCET), Belagavi, India, 21–23 May 2021; pp. 1–6. [Google Scholar]
- Rojc, M.; Ariöz, U.; Šafran, V.; Mlakar, I. Multilingual Chatbots to Collect Patient-Reported Outcomes. In Chatbots—The AI-Driven Front-Line Services for Customers; IntechOpen: London, UK, 2023; ISBN 9781837689323. [Google Scholar]
- Darius, Z.; Hundertmark, S. Chatbots—An interactive technology for personalized communication, transactions and services. IADIS Int. J. WWW/Internet 2017, 95, 96–109. Available online: https://www.researchgate.net/profile/Darius-Zumstein/publication/322855718_Chatbots_-_An_Interactive_Technology_for_Personalized_Communication_Transactions_and_Services/links/5a72ecde458515512076b406/Chatbots-An-Interactive-Technology-for-Personalized-Communication-Transactions-and-Services.pdf (accessed on 17 July 2024).
- Reshmi, S.; Balakrishnan, K. Empowering chatbots with business intelligence by big data integration. Int. J. Adv. Res. Comput. Sci. 2018, 9, 627–631. [Google Scholar] [CrossRef]
- Hopkins, A.M.; Logan, J.M.; Kichenadasse, G.; Sorich, M.J. Artificial Intelligence Chatbots Will Revolutionize How Cancer Patients Access Information: ChatGPT Represents a Paradigm-Shift. JNCI Cancer Spectr. 2023, 7, pkad010. [Google Scholar] [CrossRef] [PubMed]
- Sheehan, B.; Jin, H.S.; Gottlieb, U. Customer Service Chatbots: Anthropomorphism and Adoption. J. Bus. Res. 2020, 115, 14–24. [Google Scholar] [CrossRef]
- Følstad, A.; Skjuve, M.; Brandtzaeg, P.B. Different Chatbots for Different Purposes: Towards a Typology of Chatbots to Understand Interaction Design. In Proceedings of the Internet Science; Bodrunova, S.S., Koltsova, O., Følstad, A., Halpin, H., Kolozaridi, P., Yuldashev, L., Smoliarova, A., Niedermayer, H., Eds.; Springer International Publishing: Cham, Switzerland, 2019; pp. 145–156. [Google Scholar]
- Sharma, P. Chatbots in Medical Research: Advantages and Limitations of Artificial Intelligence–Enabled Writing With a Focus on ChatGPT as an Author. Clin. Nucl. Med. 2023, 48, 838–839. [Google Scholar] [CrossRef] [PubMed]
- Clark, M.; Bailey, S. Chatbots in Health Care: Connecting Patients to Information. Can. J. Health Technol. 2024, 4. [Google Scholar] [CrossRef]
- Fan, X.; Chao, D.; Zhang, Z.; Wang, D.; Li, X.; Tian, F. Utilization of Self-Diagnosis Health Chatbots in Real-World Settings: Case Study. J. Med. Internet Res. 2021, 23, e19928. [Google Scholar] [CrossRef] [PubMed]
- Sadasivan, C.; Cruz, C.; Dolgoy, N.; Hyde, A.; Campbell, S.; McNeely, M.; Stroulia, E.; Tandon, P. Examining Patient Engagement in Chatbot Development Approaches for Healthy Lifestyle and Mental Wellness Interventions: Scoping Review. J. Particip. Med. 2023, 15, e45772. [Google Scholar] [CrossRef] [PubMed]
- Kowatsch, T.; Nißen, M.; Shih, C.-H.I.; Rüegger, D.; Volland, D.; Filler, A.; Künzler, F.; Barata, F.; Hung, S.; Büchter, D.; et al. Text-Based Healthcare Chatbots Supporting Patient and Health Professional Teams: Preliminary Results of a Randomized Controlled Trial on Childhood Obesity; ETH Zurich: Zurich, Switzerland, 2017; 11p. [Google Scholar] [CrossRef]
- Rana, J. The Pros and Cons of Healthcare Chatbots; REVE Chat: Singapore, 2023. [Google Scholar]
- Chen, D.; Parsa, R.; Hope, A.; Hannon, B.; Mak, E.; Eng, L.; Liu, F.-F.; Fallah-Rad, N.; Heesters, A.M.; Raman, S. Physician and Artificial Intelligence Chatbot Responses to Cancer Questions from Social Media. JAMA Oncol. 2024, 10, 956–960. [Google Scholar] [CrossRef]
- Wang, A.; Qian, Z.; Briggs, L.; Cole, A.P.; Reis, L.O.; Trinh, Q.-D. The Use of Chatbots in Oncological Care: A Narrative Review. Int. J. Gen. Med. 2023, 16, 1591–1602. [Google Scholar] [CrossRef]
- Tawfik, E.; Ghallab, E.; Moustafa, A. A Nurse versus a Chatbot—The Effect of an Empowerment Program on Chemotherapy-Related Side Effects and the Self-Care Behaviors of Women Living with Breast Cancer: A Randomized Controlled Trial. BMC Nurs. 2023, 22, 102. [Google Scholar] [CrossRef] [PubMed]
- Bibault, J.-E.; Chaix, B.; Guillemassé, A.; Cousin, S.; Escande, A.; Perrin, M.; Pienkowski, A.; Delamon, G.; Nectoux, P.; Brouard, B. A Chatbot Versus Physicians to Provide Information for Patients With Breast Cancer: Blind, Randomized Controlled Noninferiority Trial. J. Med. Internet Res. 2019, 21, e15787. [Google Scholar] [CrossRef]
- Melián-González, S.; Gutiérrez-Taño, D.; Bulchand-Gidumal, J. Predicting the Intentions to Use Chatbots for Travel and Tourism. Curr. Issues Tour. 2021, 24, 192–210. [Google Scholar] [CrossRef]
- Okonkwo, C.W.; Ade-Ibijola, A. Chatbots Applications in Education: A Systematic Review. Comput. Educ. Artif. Intell. 2021, 2, 100033. [Google Scholar] [CrossRef]
- Ozuem, W.; Ranfagni, S.; Willis, M.; Salvietti, G.; Howell, K. Exploring the Relationship between Chatbots, Service Failure Recovery and Customer Loyalty: A Frustration–Aggression Perspective. Psychol. Mark. 2024; early view. [Google Scholar] [CrossRef]
- Grudin, J.; Jacques, R. Chatbots, Humbots, and the Quest for Artificial General Intelligence. In Proceedings of the 2019 CHI Conference on Human Factors in Computing Systems, Glasgow, UK, 4–9 May 2019; pp. 1–11. [Google Scholar]
- Gupta, M. Chatbots—Boon or Bane? Available online: https://blog.bluelupin.com/chatbot-advantages-and-disadvantages/ (accessed on 11 June 2024).
- Caldarini, G.; Jaf, S.; McGarry, K. A Literature Survey of Recent Advances in Chatbots. Information 2022, 13, 41. [Google Scholar] [CrossRef]
- Yang, J.; Chen, Y.-L.; Por, L.Y.; Ku, C.S. A Systematic Literature Review of Information Security in Chatbots. Appl. Sci. 2023, 13, 6355. [Google Scholar] [CrossRef]
- Bang, J.; Kim, S.; Nam, J.W.; Yang, D.-G. Ethical Chatbot Design for Reducing Negative Effects of Biased Data and Unethical Conversations. In Proceedings of the 2021 International Conference on Platform Technology and Service (PlatCon), Jeju, Republic of Korea, 23–25 August 2021; pp. 1–5. [Google Scholar]
- Singh, J.; Sillerud, B.; Singh, A. Artificial Intelligence, Chatbots and ChatGPT in Healthcare—Narrative Review of Historical Evolution, Current Application, and Change Management Approach to Increase Adoption. J. Med. Artif. Intell. 2023, 6. [Google Scholar] [CrossRef]
- Why Is AI Adoption in Health Care Lagging? Available online: https://www.brookings.edu/articles/why-is-ai-adoption-in-health-care-lagging/ (accessed on 11 June 2024).
- Brown, J.E.H.; Halpern, J. AI Chatbots Cannot Replace Human Interactions in the Pursuit of More Inclusive Mental Healthcare. SSM Ment. Health 2021, 1, 100017. [Google Scholar] [CrossRef]
- Xiao, Z.; Liao, Q.V.; Zhou, M.; Grandison, T.; Li, Y. Powering an AI Chatbot with Expert Sourcing to Support Credible Health Information Access. In Proceedings of the 28th International Conference on Intelligent User Interfaces; Association for Computing Machinery: New York, NY, USA, 2023; pp. 2–18. [Google Scholar]
- Tuncel, F.; Mumcu, B.; Tanberk, S. A Chatbot for Preliminary Patient Guidance System. In Proceedings of the 2021 29th Signal Processing and Communications Applications Conference (SIU), Istanbul, Turkey, 9–11 June 2021; pp. 1–4. [Google Scholar]
- Kuroiwa, T.; Sarcon, A.; Ibara, T.; Yamada, E.; Yamamoto, A.; Tsukamoto, K.; Fujita, K. The Potential of ChatGPT as a Self-Diagnostic Tool in Common Orthopedic Diseases: Exploratory Study. J. Med. Internet Res. 2023, 25, e47621. [Google Scholar] [CrossRef]
- Chen, S.; Kann, B.H.; Foote, M.B.; Aerts, H.J.W.L.; Savova, G.K.; Mak, R.H.; Bitterman, D.S. Use of Artificial Intelligence Chatbots for Cancer Treatment Information. JAMA Oncol. 2023, 9, 1459. [Google Scholar] [CrossRef]
- Pan, A.; Musheyev, D.; Bockelman, D.; Loeb, S.; Kabarriti, A.E. Assessment of Artificial Intelligence Chatbot Responses to Top Searched Queries About Cancer. JAMA Oncol. 2023, 9, 1437. [Google Scholar] [CrossRef]
- Tantsiura, P. 5 Challenges of Chatbots for Business and How to Overcome Them. Available online: https://theappsolutions.com/blog/development/challenges-of-chatbots-for-business/ (accessed on 12 June 2024).
- Fritsch, T. Chatbots: An Overview of Current Issues and Challenges. In Proceedings of the Advances in Information and Communication; Arai, K., Ed.; Springer Nature Switzerland: Cham, Switzerland, 2024; pp. 84–104. [Google Scholar]
- Loh, E. ChatGPT and Generative AI Chatbots: Challenges and Opportunities for Science, Medicine and Medical Leaders. BMJ Lead. 2024, 8. [Google Scholar] [CrossRef] [PubMed]
- Gökçearslan, Ş.; Tosun, C.; Erdemir, Z.G. Benefits, Challenges, and Methods of Artificial Intelligence (AI) Chatbots in Education: A Systematic Literature Review. IJTE 2024, 7, 19–39. [Google Scholar] [CrossRef]
- Tinmaz, H.; Lee, Y.-T.; Fanea-Ivanovici, M.; Baber, H. A Systematic Review on Digital Literacy. Smart Learn. Environ. 2022, 9, 21. [Google Scholar] [CrossRef]
- Rezaeikhonakdar, D. AI Chatbots and Challenges of HIPAA Compliance for AI Developers and Vendors. J. Law Med. Ethics 2024, 51, 988–995. [Google Scholar] [CrossRef] [PubMed]
- Fink, J. Can Artificial Intelligence Chatbots Convincingly Mimic Empathy? Am. J. Nurs. 2023, 123, 13. [Google Scholar] [CrossRef]
- Altamimi, I.; Altamimi, A.; Alhumimidi, A.S.; Altamimi, A.; Temsah, M.-H. Artificial Intelligence (AI) Chatbots in Medicine: A Supplement, Not a Substitute. Cureus 2023, 15, e40922. [Google Scholar] [CrossRef]
- Overman, T.; Blum, G.; Klabjan, D. A Primal-Dual Algorithm for Hybrid Federated Learning. arXiv 2022, arXiv:2210.08106. [Google Scholar] [CrossRef]
- Benjamin, R. Race after Technology: Abolitionist Tools for the New Jim Code; Polity: Cambridge, UK, 2019; p. 172. ISBN 978-1-509-52643-7. [Google Scholar]
- Cath, C. Governing Artificial Intelligence: Ethical, Legal and Technical Opportunities and Challenges. Phil. Trans. R. Soc. A 2018, 376, 20180080. [Google Scholar] [CrossRef]
- Cohen, I.G.; Amarasingham, R.; Shah, A.; Xie, B.; Lo, B. The Legal And Ethical Concerns That Arise From Using Complex Predictive Analytics In Health Care. Health Aff. 2014, 33, 1139–1147. [Google Scholar] [CrossRef]
- Vayena, E.; Blasimme, A.; Cohen, I.G. Machine Learning in Medicine: Addressing Ethical Challenges. PLoS Med. 2018, 15, e1002689. [Google Scholar] [CrossRef]
- Almalki, M.; Azeez, F. Health Chatbots for Fighting COVID-19: A Scoping Review. Acta Inf. Med. 2020, 28, 241–247. [Google Scholar] [CrossRef] [PubMed]
- Schillaci, C.E.; de Cosmo, L.M.; Piper, L.; Nicotra, M.; Guido, G. Anthropomorphic Chatbots’ for Future Healthcare Services: Effects of Personality, Gender, and Roles on Source Credibility, User Satisfaction, and Intention to Use. Technol. Forecast. Soc. Change 2024, 199, 123025. [Google Scholar] [CrossRef]
- Suppadungsuk, S.; Thongprayoon, C.; Miao, J.; Krisanapan, P.; Qureshi, F.; Kashani, K.; Cheungpasitporn, W. Exploring the Potential of Chatbots in Critical Care Nephrology. Medicines 2023, 10, 58. [Google Scholar] [CrossRef]
- Palanica, A.; Flaschner, P.; Thommandram, A.; Li, M.; Fossat, Y. Physicians’ Perceptions of Chatbots in Health Care: Cross-Sectional Web-Based Survey. J. Med. Internet Res. 2019, 21, e12887. [Google Scholar] [CrossRef]
- Tripathi, S.; Tabari, A.; Mansur, A.; Dabbara, H.; Bridge, C.P.; Daye, D. From Machine Learning to Patient Outcomes: A Comprehensive Review of AI in Pancreatic Cancer. Diagnostics 2024, 14, 174. [Google Scholar] [CrossRef] [PubMed]
- Mouliou, D.S. C-Reactive Protein: Pathophysiology, Diagnosis, False Test Results and a Novel Diagnostic Algorithm for Clinicians. Diseases 2023, 11, 132. [Google Scholar] [CrossRef] [PubMed]
- Mouliou, D.S.; Gourgoulianis, K.I. False-Positive and False-Negative COVID-19 Cases: Respiratory Prevention and Management Strategies, Vaccination, and Further Perspectives. Expert. Rev. Respir. Med. 2021, 15, 993–1002. [Google Scholar] [CrossRef]
- Mouliou, D.S.; Dardiotis, E. Current Evidence in SARS-CoV-2 mRNA Vaccines and Post-Vaccination Adverse Reports: Knowns and Unknowns. Diagnostics 2022, 12, 1555. [Google Scholar] [CrossRef]
- Mouliou, D.S.; Gourgoulianis, K.I. COVID-19 ‘Asymptomatic’ Patients: An Old Wives’ Tale. Expert. Rev. Respir. Med. 2022, 16, 399–407. [Google Scholar] [CrossRef]
- Mouliou, D.S.; Pantazopoulos, I.; Gourgoulianis, K. COVID-19 Diagnosis in the Emergency Department: Seeing the Tree but Losing the Forest. Emerg. Med. J. 2022, 39, 563. [Google Scholar] [CrossRef] [PubMed]
- Mouliou, D.S. The Deceptive COVID-19: Lessons from Common Molecular Diagnostics and a Novel Plan for the Prevention of the Next Pandemic. Diseases 2023, 11, 20. [Google Scholar] [CrossRef]
- Mouliou, D.S. Managing Viral Emerging Infectious Diseases via Current Molecular Diagnostics in the Emergency Department: The Tricky Cases. Expert Review of Anti-infective Therapy. Expert Rev. Anti-Infect. Ther. 2022, 20, 1163–1169. [Google Scholar] [CrossRef] [PubMed]
- Mouliou, D.S. John Cunningham Virus and Progressive Multifocal Leukoencephalopathy: A Falsely Played Diagnosis. Diseases 2024, 12, 100. [Google Scholar] [CrossRef] [PubMed]
Knowledge domain |
|
Service-provided |
|
Goal-based |
|
Response generation |
|
Human-aided |
|
Screening and diagnosis | Imaging diagnostic | Medical Sieve | Assesses radiologic data to help physicians’ diagnosis |
Symptom screening | Quro | Presynopsis relying on symptomatology and history to predict user’s situation | |
Buoy Health | Aids in finding the etiology of diseases and provides medical recommendations | ||
Harshitha breast cancer screening | Dialog flow providing an early diagnosis of symptomatology of breast cancer | ||
Babylon | Symptom checker | ||
Healthily (formerly Your.md) | |||
Ada | |||
Hereditary assessment | ItRuns | Collects family history data at a populace level to assess hereditary cancer | |
Treatment | Patient treatment recommendation | Mathew | Detects symptomatology and predicts the illness via a symptom–illness data set and provides appropriate treatment |
Madhu | Offers a catalog of available therapies for different illnesses and provides data to the user for the synthesis and prescribed use of medications | ||
Connecting patients with providers or resources | Divya | Engages users to provide a personalized diagnosis and links to suitable healthcare | |
Rarhi | Offers a symptom-based diagnosis and counts the seriousness and links with a physician | ||
Physician medication planning | Watson for Oncology | Evaluates information from medical records to provide a medication plan for physicians | |
Monitoring | Remote patient monitoring | STREAMD | Offers entry to healthcare instructions and educational data |
Conversa | |||
Memora Health | |||
AiCure | Coaches patients to control their condition and follow the instructions | ||
Infinity | Estimates outcomes and consequences of mobile-based monitoring for cancer cases aged ≥65 years | ||
Vik | informs about cases’ routine needs and concerns | ||
Support | Counseling | Vivobot | Cognitive and behavioral psychological help |
Emotional support | Youper | Daily support and tracking mental condition | |
Wysa | |||
Replika | |||
Unmind | |||
Shim | |||
Woebot | |||
Workflow efficiency | Administration | Sense.ly | Controls appointments and patients’ conditions and recommends medications |
CareSkore | Monitors vitals and informs the need for admissions to the hospital | ||
Mandy | Aids healthcare staff by automating case’s intake process | ||
patient encounter | HOLMeS | helps diagnosis, chooses the suitable medications and offers preventative check-ups | |
Health promotion | General lifestyle coaching | SWITCHes | Monitors case’s progress, offers help to physicians, and recommends appropriate activities |
CoachAI | |||
WeightMentor | Offers self-help activation for maintaining body weight and an open dialogue | ||
Healthy eating | Healthy Hero | Aids in deciding for foods to alter unhealthy eating habits | |
Tasteful Bot | Cognitive behavioral medication | ||
Forksy | |||
SLOWbot | |||
Smoking cessation | SMAG | ||
Bella | Helps stopping smoking |
Medical Sieve | Advantages | Disadvantages |
---|---|---|
Quro | Automation, 24/7 availability, low operational costs, scalability, uniform responses, data processing, multilingual, remote access | Limited understanding in complex queries, contextual awareness, inaccuracies, required maintenance, data privacy, cybersecurity, biases, transparency, automation impact, empathy |
Buoy Health | 24/7 availability, remote access, symptom checking, tailored advice, time saving, resource optimization, informed choices, next steps guidance | Diagnostic limitations, algorithm dependence, privacy and security concerns, limited scope, over-reliance, technical issues, ethical and regulatory challenges like bias and fairness |
Harshitha breast cancer screening | Early detection, increased awareness, self-examination, improved imaging techniques, risk reduction | False positives and false negatives, overdiagnosis of non-threatening cancers, impact on the overall quality of life, radiation exposure, financial burden, accessibility issues |
Babylon | 24/7 availability, remote access, reduced waiting times, quick symptom checking, affordable services, insurance integration, tailored advice, health monitoring, data-driven | Diagnostic limitations in complex cases, privacy and security issues, technology-dependent, app malfunctions, limited human touch, communication barriers, regulatory compliance, biases and fairness |
Healthily (former Your.md) | 24/7 availability, remote access, free services, reduced health costs, user-friendly interface, tailored advice, personal health records, data protection | Diagnostic limitations, algorithm dependence, limited scope, lack of human touch, communication barriers, internet-dependent, technical issues, over-reliance on self-diagnosis |
Ada | 24/7 availability, remote access, user-friendly interface, personalized health assessments, educational resources, privacy and security | Diagnostic limitations, algorithm-dependent, limited scope, lack of human touch, communication barriers, technology/internet-dependent, over-reliance on self-diagnosis |
ItRuns | Early detection and prevention, tailored information, customized recommendations, advanced testing, broad coverage, awareness and understanding, supportive guidance, data security and privacy | Psychological impact, false positives and false negatives, complex interpretation, high costs, accessibility issues, privacy and ethical concerns, uncertain outcomes, scope limitations |
Mathew | Early detection and prevention, tailored healthcare plans, risk reduction strategies, targeted therapies, detailed risk assessment, family health insights, informed decision-making, health literacy, at-home testing, online support | Psychological impact, false positives and false negatives, complex results, high costs, accessibility, data privacy, genetic discrimination, variable risk, incomplete coverage |
Madhu | Early detection and prevention, tailored recommendations, custom health plans, informed decisions, health awareness, at-home testing, online results, data protection | Psychological impact, false positives and false negatives, misinterpretations, financial barriers, accessibility issues, data privacy, genetic discrimination, partial coverage, lifestyle and environmental factors |
Divya | Proactive health management, customized preventive strategies, tailored recommendations, custom health plans, at-home testing, online results and support, informed decision-making, health literacy, data protection | Psychological impact, false positives and false negatives, misinterpretations, financial barriers, accessibility issues, data privacy, genetic discrimination, partial coverage, lifestyle and environmental factors |
Rarhi | Proactive health management, preventive interventions, customized recommendations, tailored health plans, at-home testing kits, online results, understanding genetic risks, health awareness, data protection | Psychological impact, false positives and false negatives, complex results, financial barriers, limited access, data privacy, genetic discrimination, partial coverage, lifestyle and environmental factors |
Watson for Oncology | Evidence-based recommendations, up-to-date information, rapid analysis, time saving, integration of multimodal data, personalized treatment, knowledge sharing, training and support | Performance variability, error rate, health system integration issues, data compatibility, data limitations, dependence on data quality, high costs, training and support, liability issues, patient privacy |
STREAMD | comprehensive data view, improved data access, predictive analytics, personalized care, streamlined processes, clinical alerts, patient portal, health monitoring | data quality, false positives and false negatives, system compatibility, data standardization, data privacy, risk of breaches, high costs, training needs, technical issues, over-reliance on AI |
Conversa | Improved communication, patient education, remote access, 24/7 availability, tailored interactions, health monitoring, streamlined processes, data integration, actionable insights, performance tracking | System compatibility, technical issues, data privacy, regulatory compliance, implementation costs, subscription fees, learning curve, resistance to change, reduced face-to-face interactions, possible miscommunication |
Memora Health | Personalized communication, improved adherence, 24/7 availability, remote monitoring, automated workflows, data integration, centralized communication, collaborative tools, actionable analytics, performance tracking | System compatibility, technical issues, data privacy, regulatory compliance, implementation costs, subscription fees, user adoption and training–learning curve and resistance to change, over-reliance on automation, miscommunication risks |
AiCure | Real-time monitoring, adherence support, interactive interface, behavioral insights, data-driven outcomes, automated process, remote management, improved data accuracy, real-time feedback | Data privacy, compliance issues, system compatibility, technical issues, user adoption and training–learning curve and resistance to technology, AI limitations, false positives and false negatives, implementation costs, subscription fees |
Infinity | Comprehensive data integration, streamlined processes, tailored recommendations, adaptive algorithms, data-driven insights, predictive analytics, remote access, 24/7 availability, enhanced data collection, real-time monitoring | Data privacy, regulatory compliance, system compatibility, technical glitches, high costs, subscription fees, user adoption and training–learning curve and resistance to change, dependence on data quality, possible misinterpretations |
Vik | Personalized recommendations, 24/7 accessibility, automated processes, streamlined workflows, actionable analytics, predictive capabilities, remote access, user-friendly interface | Data protection, compliance, system compatibility, technical problems, high implementation costs, subscription fees, training needs, resistance to change, dependence on data quality, possible misinterpretations |
Vivobot | AI-powered conversations, behavioral insights, medication reminders, health monitoring, streamlined engagement, data collection, accessible everywhere, real-time feedback | Data security, regulatory compliance, AI limitations, technical issues, implementation costs, ongoing fees, user adoption and training–learning curve, resistance to new technology, dependence on data accuracy, miscommunication risks |
Youper | Tailored interactions, adaptive learning, 24/7 availability, easy to use, mood monitoring, data insights, real-time feedback | Limited understanding, miscommunication risks, data privacy and security, compliance issues, resistance to technology, technology-dependent, subscription fees |
Wysa | Evidence-based cognitive behavioral therapy and therapeutic exercises, 24/7 accessibility, user-friendly, custom interactions, mood tracking, connection to human therapists | Lack of human empathy, misunderstanding risks, sensitive information, compliance issues, high cost for premium features, technology-dependent |
Replika | Companionship, conversational AI, self-improvement tools, emotional insights, 24/7 availability, easy to use, personalized experience, | Limited emotional depth, miscommunication risks, data privacy and security, regulatory compliance, AI-dependent, in-app purchases |
Unmind | Holistic approach, evidence-based content, tailored for organizations, engagement metrics, 24/7 accessibility, user-friendly, proactive approach | Sensitive data, compliancy, privacy and security concerns, genetic resources, employee participation, subscription fees |
Shim | Customized interactions, behavioral insights, 24/7 availability, user-friendly, immediate support, adaptability | Complex issues misinterpretation, miscommunication risk, sensitive data handling, compliance, privacy and security concerns, user engagements, potential costs for premium features/services |
Woebot | Evidence-based cognitive behavioral therapy, research backed, 24/7 support, user-friendly, real-time conversations, affordable access | Limited depth, miscommunication risks, data privacy and security, regulatory compliance, resistant to technology, dependency risk |
Sense.ly | Virtual assistant, real-time interaction, patient tracking, data integration, accessible anywhere, 24/7 availability, personalized interactions | AΙ limitations in understanding complex conditions, possible miscommunications, data privacy and security, regulatory compliance, system compatibility, technical issues, implementation costs |
CareSkore | Risk evaluation, personalized recommendations, holistic view, continuous monitoring, intuitive design, accessibility, early intervention | Sensitive data handling, regulatory compliance, dependence on data quality, misinterpretation risks, subscription fees, adherence challenges |
Mandy | Tailored resources, adaptive learning, 24/7 access, user-friendly, variety of resources, behavioral insights, data protection | AI limitations in understanding complex issues, miscommunication risks, user motivation, cost consideration for some premium features, technology-dependent |
HOLMeS | Personalized interventions, health tracking, comprehensive health data, real-time updates, interactive tools, educational content, multi-platform availability | Sensitive information, regulatory compliance, user learning curve, integration challenges, complexity, implementation costs, AI algorithm accuracy |
SWITCHes | Personalized coaching, goal setting, interactive features, feedback mechanisms, 24/7 availability, user-friendly, evidence-based scientific principles | Privacy and security, data management, regulatory compliance, user adherence, subscription fees, personalization AI limits |
CoachAI | Tailored recommendations, adaptive learning, 24/7 accessibility, user-friendly, data-driven insights, real-time feedback, scalability | Understanding complex needs, miscommunication risks, data privacy and security, regulatory compliance, motivation challenges, subscription costs, usage fees |
WeightMentor | Customized plans, adaptive feedback, comprehensive tracking, data insights, motivation tools, educational content, ease to use | Complex AI needs, misinterpretation risks, sensitive data handling, regulatory compliance, consistency, subscription fees |
Healthy Hero | Comprehensive wellness, personalized recommendations, informative content, interactive features, goal setting, progress insights, motivation tools | Personalization limits, possible miscommunication, data privacy and security, regulatory compliance, consistency, cost for premium features |
Tasteful Bot | Nutritional guidance with healthy recipes and nutritional information, dietary preferences based on user and adaptive suggestions, easy access, 24/7 availability, interactive experience | Limitations in complex dietary needs, risks for inaccurate recommendations, data management, regulatory compliance, adherence challenges, costs for premium features |
Forksy | Tailored recommendations, adaptive algorithms, comprehensive health view, real-time monitoring interactive features, educational content, accessible anywhere | Limitations in complex conditions, data accuracy, data privacy and security, regulatory compliance, consistency, potential fees |
SLOWbot | Slow-paced interactions, stress reduction, engaging experience, personalization, accessible anytime, easy to use, mindfulness resources, | Depth of support, possible miscommunication, user adherence, data management, niche focus |
SMAG | Real-time tracking, adaptive recommendations, holistic view, actionable insights, interactive tools, educational resources, accessible across devices | Limitations in accuracy and interpretation, complex health issues, sensitive data, data privacy and security issues, regulatory compliance, subscription fees, adherence |
Bella | Comprehensive approach, personalized interactions, engaging experience, real-time feedback, informative content, 24/7 access, user-friendly | Depth of support, miscommunication risks, data privacy and security issues, consistency, cost for premium features |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Goumas, G.; Dardavesis, T.I.; Syrigos, K.; Syrigos, N.; Simou, E. Chatbots in Cancer Applications, Advantages and Disadvantages: All that Glitters Is Not Gold. J. Pers. Med. 2024, 14, 877. https://doi.org/10.3390/jpm14080877
Goumas G, Dardavesis TI, Syrigos K, Syrigos N, Simou E. Chatbots in Cancer Applications, Advantages and Disadvantages: All that Glitters Is Not Gold. Journal of Personalized Medicine. 2024; 14(8):877. https://doi.org/10.3390/jpm14080877
Chicago/Turabian StyleGoumas, Georgios, Theodoros I. Dardavesis, Konstantinos Syrigos, Nikolaos Syrigos, and Effie Simou. 2024. "Chatbots in Cancer Applications, Advantages and Disadvantages: All that Glitters Is Not Gold" Journal of Personalized Medicine 14, no. 8: 877. https://doi.org/10.3390/jpm14080877